Tidal Investments’s Viking Therapeutics VKTX Stock Holding History

Tidal Investments’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$943K	Sell	24,186 -15,368	-39%	-$496K	﹤0.01%	1774
2026 Q1	$1.29M	Buy	39,554 +14,834	+60%	+$477K	﹤0.01%	1321
2025 Q4	$870K	Sell	24,720 -6,500	-21%	-$230K	﹤0.01%	1353
2025 Q3	$820K	Buy	31,220 +21,733	+229%	+$648K	﹤0.01%	1314
2025 Q2	$251K	Buy	+9,487	New	+$250K	﹤0.01%	1696
2024 Q4	–	Sell	-15,190	Closed	-$962K	–	2004
2024 Q3	$962K	Buy	15,190 +11,362	+297%	+$667K	0.01%	1005
2024 Q2	$203K	Sell	3,828 -25,045	-87%	-$1.64M	﹤0.01%	1689
2024 Q1	$2.37M	Buy	+28,873	New	+$1.28M	0.04%	465

Other funds holding VKTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Tidal Investments's VKTX Position: Q2 2026 in Review

Tidal Investments reduced its Viking Therapeutics (VKTX) stake by 39% in Q2 2026, selling an estimated $496K and leaving 24,186 shares worth $943K. The position accounts for ﹤0.01% of the portfolio, ranked #1774.

Tidal Investments first reported a position in VKTX in Q1 2024 and has held it in 8 quarters since. The position peaked at $2.37M in Q1 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

Tidal Investments held 24,186 shares of Viking Therapeutics worth $943K as of Q2 2026.
Tidal Investments sold 15,368 Viking Therapeutics shares in Q2 2026, an estimated $496K.
Viking Therapeutics made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1774 holding.
Tidal Investments first reported a position in Viking Therapeutics in Q1 2024 and has held it in 8 quarters since.
Tidal Investments's Viking Therapeutics position peaked at $2.37M in Q1 2024.
436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.